Aurora Cannabis (ACB) Gains from Investment Securities (2017 - 2024)

Aurora Cannabis (ACB) has reported Gains from Investment Securities for 6 consecutive years, with -$2.2 million the latest figure, recorded in Q4 2023.

• In Q4 2023, Gains from Investment Securities fell 2958.32% year-over-year to -$2.2 million; the TTM figure through Dec 2023 stood at -$4.8 million (down 15.49% YoY), while the FY2023 annual figure was $1.6 million, up 204.72% from the prior year.
• Gains from Investment Securities retreated to -$2.2 million in Q4 2023 per ACB's latest filing, from -$72196.9 in the prior quarter.
• Across five years, Gains from Investment Securities topped out at $8.7 million in Q1 2020 and bottomed at -$2.6 million in Q2 2020.
• Historically, Gains from Investment Securities has averaged $353379.5 across 4 years, with a median of -$73669.0 in 2022.
• Annual changes were most pronounced in 2019 — Gains from Investment Securities soared 215.47% — and 2023, when it slumped 2958.32%.
• Aurora Cannabis' Gains from Investment Securities stood at $756740.9 in 2019, then tumbled by 443.76% to -$2.6 million in 2020, then jumped by 97.22% to -$72196.9 in 2022, then plunged by 2958.32% to -$2.2 million in 2023.
• Business Quant data shows ACB's Gains from Investment Securities at -$2.2 million in Q4 2023, -$72196.9 in Q4 2022, and -$75141.1 in Q3 2022.